X
Archive by author: Lindsey HoughtonReturn
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team is changing the acceptable shipping conditions for samples requiring this test. Effective immediately, samples requiring Monolisa anti-HBs EIA testing must be shipped directly to Special Testing in CTS Phoenix at 2-8 C using wet ice or frozen using dry ice.Samples submitted to CTS in the routine donor sample shipper will be deemed unacceptable for the Monolisa anti-HBs EIA test. If you have questi...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.Thanks for your support as we work to rapidly get this testing available to you. &nbs...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: 
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020. Click here for all the details:
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive test result files, due to the old sFTP server needing to be decommissioned.Get the details here:Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ultrio Assay to the Grifols Procleix Ultrio Elite Assay on the fully automated Panther System.Read all about it on the Communication page by clicking the this link:Communications
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.Read about our plan to mitigate this on the Communications page by clicking this link: Communications&l...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in atten...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols  Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.Check out the Communication page for the complete details by clicking the link:
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.Check out the Communication page for the complete details by clicking the link:

Subscribe here to receive CTS updates!

Name